Clinical significance of side population in ovarian cancer cells

Human Cell

Volumn 24, Issue 1, 2011, Pages 9-12

  Hosonuma, Shinji ^a   Kobayashi, Yoichi ^a,b   Kojo, Satoshi ^a   Wada, Haruka ^a   Seino, Ken ichiro ^a   Kiguchi, Kazushige ^a   Ishizuka, Bunpei ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer stem cells (CSCs); Ovarian cancer; Prognosis; Side population (SP)

Indexed keywords

CELL MARKER;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STAGING; CANCER STEM CELL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; SIDE POPULATION CELL;

ADULT; AGED; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PROGNOSIS; SIDE-POPULATION CELLS;

EID: 79952981884     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1007/s13577-010-0002-z     Document Type: Article

References (17)

1. Lambrou N, Trimble EL. Dose-intensive approaches to ovarian cancer. Curr Oncol Rep. 1999; 1: 54-8.
2. Wulf GG, Wang RY, Kuehnle I, et al. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood. 2001; 98: 1166-73.
3. Hadnagy A, Gaboury L, Beaulieu R, et al. SP analysis may be used to identify cancer stem cell populations. Exp Cell Res. 2006; 312: 3701-10.
4. Wu C, Alman BA. Side population cells in human cancers. Cancer Lett. 2008; 268: 1-9.
5. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003; 100: 3983-8.
6. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007; 445: 111-5.
7. Cui L, Ohuchida K, Mizumoto K, et al. Prospectively isolated cancer-associated CD10 fibroblasts have stronger interactions with CD133 colon cancer cells than with CD133 cancer cells. PLoS One. 2010; 5: e12121.
8. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007; 67: 1030-7.
9. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA. 2006; 103: 11154-9.
10. Bapat SA, Mali AM, Koppikar CB, et al. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 2005; 65: 3025-9.
11. Challen GA, Little MH. A side order of stem cells: the SP phenotype. Stem Cells. 2006; 24: 3-12.
12. Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA. 2004; 101: 14228-33.
13. Pan Y, Huang X. Epithelial ovarian cancer stem cells-a review. Int J Clin Exp Med. 2008; 1: 260-6.
14. Hu L, McArthur C, Jaffe RB. Ovarian cancer stem-like side-population cells are tumourigenic, chemoresistant. Br J Cancer. 2010; 102: 1276-83.
15. Alvero AB, Fu HH, Holmberg J, et al. Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells. 2009; 27: 2405-13.
16. Fong MY, Kakar SS. The role of cancer stem cells, the side population in epithelial ovarian cancer. Histol Histopathol. 2010; 25: 113-20.
17. Takaishi K, Komohara Y, Tashiro H, et al. Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation. Cancer Sci. 2010; 101: 2128-36.